Copyright Reports & Markets. All rights reserved.

Global Diabetes Drug Therapy Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Diabetes Drug Therapy Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Diabetes Drug Therapy Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Glucagon-likepeptide-1 (GLP-1)agonist
    • 1.4.3 Dipeptidyl-peptidase-4 (DPP-4)inhibitors
    • 1.4.4 Sodium glucoseco-transporter 2 (SGLT2)inhibitors
    • 1.4.5 Insulin
    • 1.4.6 Others
  • 1.5 Market by Application
    • 1.5.1 Global Diabetes Drug Therapy Market Share by Application: 2020 VS 2026
    • 1.5.2 Type1 Diabetes
    • 1.5.3 Type2 Diabetes
    • 1.5.4 GestationalDiabetes
    • 1.5.5 ImpairedGlucoseToleranceandImpairedFasting Glycaemia
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends

  • 2.1 Global Diabetes Drug Therapy Market Perspective (2015-2026)
  • 2.2 Global Diabetes Drug Therapy Growth Trends by Regions
    • 2.2.1 Diabetes Drug Therapy Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Diabetes Drug Therapy Historic Market Share by Regions (2015-2020)
    • 2.2.3 Diabetes Drug Therapy Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Diabetes Drug Therapy Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Diabetes Drug Therapy Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Diabetes Drug Therapy Players by Market Size
    • 3.1.1 Global Top Diabetes Drug Therapy Players by Revenue (2015-2020)
    • 3.1.2 Global Diabetes Drug Therapy Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Diabetes Drug Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Diabetes Drug Therapy Market Concentration Ratio
    • 3.2.1 Global Diabetes Drug Therapy Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Diabetes Drug Therapy Revenue in 2019
  • 3.3 Diabetes Drug Therapy Key Players Head office and Area Served
  • 3.4 Key Players Diabetes Drug Therapy Product Solution and Service
  • 3.5 Date of Enter into Diabetes Drug Therapy Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Diabetes Drug Therapy Historic Market Size by Type (2015-2020)
  • 4.2 Global Diabetes Drug Therapy Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

  • 5.1 Global Diabetes Drug Therapy Market Size by Application (2015-2020)
  • 5.2 Global Diabetes Drug Therapy Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Diabetes Drug Therapy Market Size (2015-2020)
  • 6.2 Diabetes Drug Therapy Key Players in North America (2019-2020)
  • 6.3 North America Diabetes Drug Therapy Market Size by Type (2015-2020)
  • 6.4 North America Diabetes Drug Therapy Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Diabetes Drug Therapy Market Size (2015-2020)
  • 7.2 Diabetes Drug Therapy Key Players in Europe (2019-2020)
  • 7.3 Europe Diabetes Drug Therapy Market Size by Type (2015-2020)
  • 7.4 Europe Diabetes Drug Therapy Market Size by Application (2015-2020)

8 China

  • 8.1 China Diabetes Drug Therapy Market Size (2015-2020)
  • 8.2 Diabetes Drug Therapy Key Players in China (2019-2020)
  • 8.3 China Diabetes Drug Therapy Market Size by Type (2015-2020)
  • 8.4 China Diabetes Drug Therapy Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Diabetes Drug Therapy Market Size (2015-2020)
  • 9.2 Diabetes Drug Therapy Key Players in Japan (2019-2020)
  • 9.3 Japan Diabetes Drug Therapy Market Size by Type (2015-2020)
  • 9.4 Japan Diabetes Drug Therapy Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Diabetes Drug Therapy Market Size (2015-2020)
  • 10.2 Diabetes Drug Therapy Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Diabetes Drug Therapy Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Diabetes Drug Therapy Market Size by Application (2015-2020)

11 India

  • 11.1 India Diabetes Drug Therapy Market Size (2015-2020)
  • 11.2 Diabetes Drug Therapy Key Players in India (2019-2020)
  • 11.3 India Diabetes Drug Therapy Market Size by Type (2015-2020)
  • 11.4 India Diabetes Drug Therapy Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Diabetes Drug Therapy Market Size (2015-2020)
  • 12.2 Diabetes Drug Therapy Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Diabetes Drug Therapy Market Size by Type (2015-2020)
  • 12.4 Central & South America Diabetes Drug Therapy Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Abbott Laboratories
    • 13.1.1 Abbott Laboratories Company Details
    • 13.1.2 Abbott Laboratories Business Overview
    • 13.1.3 Abbott Laboratories Diabetes Drug Therapy Introduction
    • 13.1.4 Abbott Laboratories Revenue in Diabetes Drug Therapy Business (2015-2020))
    • 13.1.5 Abbott Laboratories Recent Development
  • 13.2 Mannkind Corporation
    • 13.2.1 Mannkind Corporation Company Details
    • 13.2.2 Mannkind Corporation Business Overview
    • 13.2.3 Mannkind Corporation Diabetes Drug Therapy Introduction
    • 13.2.4 Mannkind Corporation Revenue in Diabetes Drug Therapy Business (2015-2020)
    • 13.2.5 Mannkind Corporation Recent Development
  • 13.3 Bristol Myers Squibb
    • 13.3.1 Bristol Myers Squibb Company Details
    • 13.3.2 Bristol Myers Squibb Business Overview
    • 13.3.3 Bristol Myers Squibb Diabetes Drug Therapy Introduction
    • 13.3.4 Bristol Myers Squibb Revenue in Diabetes Drug Therapy Business (2015-2020)
    • 13.3.5 Bristol Myers Squibb Recent Development
  • 13.4 Medtronic
    • 13.4.1 Medtronic Company Details
    • 13.4.2 Medtronic Business Overview
    • 13.4.3 Medtronic Diabetes Drug Therapy Introduction
    • 13.4.4 Medtronic Revenue in Diabetes Drug Therapy Business (2015-2020)
    • 13.4.5 Medtronic Recent Development
  • 13.5 AstraZeneca
    • 13.5.1 AstraZeneca Company Details
    • 13.5.2 AstraZeneca Business Overview
    • 13.5.3 AstraZeneca Diabetes Drug Therapy Introduction
    • 13.5.4 AstraZeneca Revenue in Diabetes Drug Therapy Business (2015-2020)
    • 13.5.5 AstraZeneca Recent Development
  • 13.6 Eli Lilly and Company
    • 13.6.1 Eli Lilly and Company Company Details
    • 13.6.2 Eli Lilly and Company Business Overview
    • 13.6.3 Eli Lilly and Company Diabetes Drug Therapy Introduction
    • 13.6.4 Eli Lilly and Company Revenue in Diabetes Drug Therapy Business (2015-2020)
    • 13.6.5 Eli Lilly and Company Recent Development
  • 13.7 GlaxoSmithKline
    • 13.7.1 GlaxoSmithKline Company Details
    • 13.7.2 GlaxoSmithKline Business Overview
    • 13.7.3 GlaxoSmithKline Diabetes Drug Therapy Introduction
    • 13.7.4 GlaxoSmithKline Revenue in Diabetes Drug Therapy Business (2015-2020)
    • 13.7.5 GlaxoSmithKline Recent Development
  • 13.8 Sanofi
    • 13.8.1 Sanofi Company Details
    • 13.8.2 Sanofi Business Overview
    • 13.8.3 Sanofi Diabetes Drug Therapy Introduction
    • 13.8.4 Sanofi Revenue in Diabetes Drug Therapy Business (2015-2020)
    • 13.8.5 Sanofi Recent Development
  • 13.9 Novo Nordisk
    • 13.9.1 Novo Nordisk Company Details
    • 13.9.2 Novo Nordisk Business Overview
    • 13.9.3 Novo Nordisk Diabetes Drug Therapy Introduction
    • 13.9.4 Novo Nordisk Revenue in Diabetes Drug Therapy Business (2015-2020)
    • 13.9.5 Novo Nordisk Recent Development
  • 13.10 Novartis International AG
    • 13.10.1 Novartis International AG Company Details
    • 13.10.2 Novartis International AG Business Overview
    • 13.10.3 Novartis International AG Diabetes Drug Therapy Introduction
    • 13.10.4 Novartis International AG Revenue in Diabetes Drug Therapy Business (2015-2020)
    • 13.10.5 Novartis International AG Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Diabetes Drug Therapy market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Diabetes Drug Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    The key players covered in this study
    Abbott Laboratories
    Mannkind Corporation
    Bristol Myers Squibb
    Medtronic
    AstraZeneca
    Eli Lilly and Company
    GlaxoSmithKline
    Sanofi
    Novo Nordisk
    Novartis International AG

    Market segment by Type, the product can be split into
    Glucagon-likepeptide-1 (GLP-1)agonist
    Dipeptidyl-peptidase-4 (DPP-4)inhibitors
    Sodium glucoseco-transporter 2 (SGLT2)inhibitors
    Insulin
    Others
    Market segment by Application, split into
    Type1 Diabetes
    Type2 Diabetes
    GestationalDiabetes
    ImpairedGlucoseToleranceandImpairedFasting Glycaemia

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    Buy now